Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, offering steady, higher-purity materials for ageing and cancer investigation. each day laboratory workflows normally expose a persistent challenge: the sluggish and inefficient removing of senescent cells that impair tiss